These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 27260776)
1. Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologies. Schwarz T; Seidl C; Schiemann M; Senekowitsch-Schmidtke R; Krause BJ Nucl Med Biol; 2016 Jun; 43(6):355-9. PubMed ID: 27260776 [TBL] [Abstract][Full Text] [Related]
2. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells. Hara T; Bansal A; DeGrado TR Nucl Med Biol; 2006 Nov; 33(8):977-84. PubMed ID: 17127170 [TBL] [Abstract][Full Text] [Related]
4. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435 [TBL] [Abstract][Full Text] [Related]
5. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555 [TBL] [Abstract][Full Text] [Related]
6. Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines? Emonds KM; Swinnen JV; van Weerden WM; Vanderhoydonc F; Nuyts J; Mortelmans L; Mottaghy FM Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1842-53. PubMed ID: 21732108 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147 [TBL] [Abstract][Full Text] [Related]
8. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer]. García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948 [TBL] [Abstract][Full Text] [Related]
9. The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer. Yi C; Yu D; Shi X; Zhang X; Luo G; He Q; Zhang X Nucl Med Commun; 2016 Mar; 37(3):239-46. PubMed ID: 26588068 [TBL] [Abstract][Full Text] [Related]
10. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions. Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255 [TBL] [Abstract][Full Text] [Related]
11. PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholine. Israel I; Richter D; Stritzker J; van Ooschot M; Donat U; Buck AK; Samnick S Curr Cancer Drug Targets; 2014; 14(4):371-9. PubMed ID: 24720338 [TBL] [Abstract][Full Text] [Related]
12. Roppongi M; Izumisawa M; Terasaki K; Muraki Y; Shozushima M Ann Nucl Med; 2019 Apr; 33(4):237-243. PubMed ID: 30588580 [TBL] [Abstract][Full Text] [Related]
13. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694 [TBL] [Abstract][Full Text] [Related]
14. (18)F-choline PET/CT pitfalls in image interpretation: an update on 300 examined patients with prostate cancer. Calabria F; Chiaravalloti A; Schillaci O Clin Nucl Med; 2014 Feb; 39(2):122-30. PubMed ID: 24368525 [TBL] [Abstract][Full Text] [Related]
15. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells. Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC). Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386 [TBL] [Abstract][Full Text] [Related]
18. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation? Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424 [TBL] [Abstract][Full Text] [Related]
19. The Utility of [ Beinat C; Haywood T; Chen YS; Patel CB; Alam IS; Murty S; Gambhir SS Mol Imaging Biol; 2018 Dec; 20(6):1015-1024. PubMed ID: 29736561 [TBL] [Abstract][Full Text] [Related]
20. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients. Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]